1. Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series.
- Author
-
Agarwal M, Sachdeva M, Pal S, Shah H, Kumar R M, and Banker A
- Subjects
- Adult, Bacteria isolation & purification, COVID-19 epidemiology, Endophthalmitis diagnosis, Endophthalmitis microbiology, Eye Infections, Bacterial diagnosis, Eye Infections, Bacterial microbiology, Eye Infections, Fungal diagnosis, Eye Infections, Fungal microbiology, Follow-Up Studies, Fungi isolation & purification, Humans, India epidemiology, Male, Middle Aged, Retrospective Studies, COVID-19 complications, Endophthalmitis etiology, Eye Infections, Bacterial etiology, Eye Infections, Fungal etiology, Pandemics, Visual Acuity, Vitreous Body microbiology
- Abstract
Purpose: To report six patients with endogenous endophthalmitis as a complication of COVID-19 infection., Methods: A multicentric retrospective database review of patients with a diagnosis of endogenous endophthalmitis and a history of COVID-19 infection., Results: Four of six patients were diabetics. All presented after an average duration of 40 days (Range 17-90 days) of COVID-19 infection. Two of six patients had bilateral involvement. Five of six patients had received intravenous corticosteroid for COVID-19. Two of six vitreous samples showed fungi ( Candida and Bipolaris species), two showed bacteria ( Staphylococcus species) and two samples were culture negative . Control of infection with good visual outcome in four out of eight eyes., Conclusions: COVID-19 patients with a history of hospitalization and prolonged use of systemic corticosteroids and comorbidities, for example, diabetes mellitus have a high risk of endogenous endophthalmitis. A high index of clinical suspicion with timely intervention can salvage many eyes.
- Published
- 2021
- Full Text
- View/download PDF